Immune Checkpoint Inhibitor-Associated Thrombotic Thrombocytopenic Purpura in a Patient With Metastatic Non-Small-Cell Lung Cancer

Background: Immune-related adverse events (irAEs) are secondary reactions related to treatment with immune checkpoint inhibitors (ICIs). There have been six cases published reporting on an association between patients undergoing treatment with ICIs and the occurrence of acquired thrombotic thrombocy...

Descripción completa

Detalles Bibliográficos
Autores principales: De Filippis, Samantha, Moore, Colton, Ezell, Kristin, Aggarwal, Kunal, Kelkar, Amar H
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321598/
https://www.ncbi.nlm.nih.gov/pubmed/34345535
http://dx.doi.org/10.7759/cureus.16035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321598/
https://www.ncbi.nlm.nih.gov/pubmed/34345535
http://dx.doi.org/10.7759/cureus.16035

Ejemplares similares